Key Market Indicators
German Pharmaceutical R&D Expenditure is projected to hit approximately $9 billion PPP by 2028, up from $8 billion PPP in 2023. This growth represents an average annual increase of 1.9%. Historical data reveals that since 2012, Germany's pharmaceutical research and development spending has been rising at an average rate of 2.2% per year. As of 2023, Germany holds the third spot globally in pharmaceutical R&D expenditure. However, China has recently surpassed Germany with expenditures matching $8 billion PPP. In the global ranking for 2023, China, Germany, and South Korea occupy the second, third, and fourth positions, respectively.
